TG Therapeutics

is a biopharmaceutical company focused on the development of
novel treatments for B-cell malignancies and autoimmune diseases.

 

Click for full image >>

For Investors

NASDAQ: TGTX
Stock Quote at: Dec 5, 4:00PM EST

Last: $5.70

Change: $0.20 (3.64%)

Quotes provided by Google - Min 15 minute delay